BHRB vs TSHA
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
BHRB · Burke & Herbert Financial Services$69.88 ▲ 0.03%
TSHA · Taysha Gene Therapies$4.33 ▲ 5.87%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- BHRB +18.0%
- TSHA +11.3%
Head to head
| Metric | BHRB | TSHA |
|---|---|---|
| Price | $69.88 | $4.33 |
| Change today | ▲ 0.03% | ▲ 5.87% |
| Market cap | $1.41B | $1.41B |
| Return, 3 months | -3.2% | -32.0% |
| Return, year to date | +14.9% | -21.3% |
| Return, 1 year | +19.6% | +13.1% |
| P/E (TTM) | 11.6 | – |
| P/B | 1.2 | 3.6 |
| P/E percentile vs own 5y | 51st | 21st |
| Dividend yield | 3.15% | – |
| Revenue growth (YoY, latest qtr) | +40.1% | -100.0% |
| Net profit growth (YoY) | +21.4% | -73.5% |
| Gross margin | – | – |
| Operating margin | – | -2,854.9% |
| Net margin | 26.1% | -2,728.0% |
| Return on equity | 10.5% | -47.1% |
| Analyst target vs. price | +11.6% | +237.2% |
| Analyst buy share | 50% | 100% |
| RSI (14) | 48 | 51 |
| 30-day volatility | 21.5% | 76.5% |
| Max drawdown, 1 year | -13.1% | -49.7% |
| Trend read | Leaning bearish | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- TSHA is the largest of the group by market value.
- BHRB has returned the most over the past year.
- BHRB is growing revenue fastest.
- BHRB keeps the most profit per dollar of sales.
- BHRB has been the calmest stock over the last 30 days.